Next Article in Journal
The EPS Matrix as an Adaptive Bastion for Biofilms: Introduction to Special Issue
Next Article in Special Issue
Does the Neuroprotective Role of Anandamide Display Diurnal Variations?
Previous Article in Journal
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis
Previous Article in Special Issue
Onjisaponin B Derived from Radix Polygalae Enhances Autophagy and Accelerates the Degradation of Mutant α-Synuclein and Huntingtin in PC-12 Cells
Article Menu

Export Article

Open AccessTechnical Note
Int. J. Mol. Sci. 2013, 14(12), 23289-23296; doi:10.3390/ijms141223289

An Exploratory Evaluation of Tyrosine Hydroxylase Inhibition in Planaria as a Model for Parkinsonism

Department of Psychiatry, College of Medicine, University of Florida, Gainesville, FL 32611, USA
Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA
Current Address: College of Engineering, University of Texas at Arlington, Arlington, TX 76203, USA
Current Address: College of Arts and Science, University of North Texas, Denton, TX 76203, USA
Current Address: Thermo Fisher Scientific, West Palm Beach, FL 33407, USA
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Received: 11 October 2013 / Revised: 18 November 2013 / Accepted: 19 November 2013 / Published: 26 November 2013
(This article belongs to the Special Issue Neuroprotective Strategies 2014)
View Full-Text   |   Download PDF [677 KB, uploaded 19 June 2014]   |  


Planaria are the simplest organisms with bilateral symmetry and a central nervous system (CNS) with cephalization; therefore, they could be useful as model organisms to investigate mechanistic aspects of parkinsonism and to screen potential therapeutic agents. Taking advantage of the organism’s anti-tropism towards light, we measured a significantly reduced locomotor velocity in planaria after exposure to 3-iodo-L-tyrosine, an inhibitor of tyrosine hydroxylase that is an enzyme catalyzing the first and rate-limiting step in the biosynthesis of catecholamines. A simple semi-automatic assay using videotaped experiments and subsequent evaluation by tracking software was also implemented to increase throughput. The dopaminergic regulation of locomotor velocity was confirmed by bromocriptine, a drug whose mechanisms of action to treat Parkinson’s disease is believed to be through the stimulation of nerves that control movement. View Full-Text
Keywords: planaria; parkinsonism; tyrosine hydroxylase; monoiodotyrosine; bromocriptine; antiparkinsonian agent planaria; parkinsonism; tyrosine hydroxylase; monoiodotyrosine; bromocriptine; antiparkinsonian agent
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Prokai, D.; Nguyen, T.; Kamrowski, K.; Chandra, A.; Talamantes, T.; Baxter, L.R.; Prokai, L. An Exploratory Evaluation of Tyrosine Hydroxylase Inhibition in Planaria as a Model for Parkinsonism. Int. J. Mol. Sci. 2013, 14, 23289-23296.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top